Bausch & Lomb (TSX:BLCO) EV-to-Revenue

: 2.30 (As of Today)

View and export this data going back to 2022. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bausch & Lomb's enterprise value is C$12,865 Mil. Bausch & Lomb's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$5,585 Mil. Therefore, Bausch & Lomb's EV-to-Revenue for today is 2.30.

The historical rank and industry rank for Bausch & Lomb's EV-to-Revenue or its related term are showing as below:

TSX:BLCO' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.88 Med: 2.22 Max: 2.6
Current: 2.3

During the past 6 years, the highest EV-to-Revenue of Bausch & Lomb was 2.60. The lowest was 1.88. And the median was 2.22.

TSX:BLCO's EV-to-Revenue is ranked better than
59.03% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3 vs TSX:BLCO: 2.30

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-23), Bausch & Lomb's stock price is C$20.09. Bausch & Lomb's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$15.94. Therefore, Bausch & Lomb's PS Ratio for today is 1.26.

Bausch & Lomb EV-to-Revenue Historical Data

The historical data trend for Bausch & Lomb's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

2.01

2.47

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial											2.01	2.22	2.35	2.56	2.47

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb EV-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's EV-to-Revenue falls into.

Bausch & Lomb EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bausch & Lomb's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	12864.925	/	5585.257
	=	2.30

Bausch & Lomb's current Enterprise Value is C$12,865 Mil.
Bausch & Lomb's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$5,585 Mil.

Bausch & Lomb (TSX:BLCO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bausch & Lomb's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	20.09	/	15.939
	=	1.26

Bausch & Lomb's share price for today is C$20.09.
Bausch & Lomb's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$15.94.

Bausch & Lomb EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.